Tifuvirtide

Drug Profile

Tifuvirtide

Alternative Names: R-724; T-1249; TMC-1249

Latest Information Update: 14 Jul 2010

Price : $50

At a glance

  • Originator Trimeris
  • Developer Monogram Biosciences; Roche; Trimeris
  • Class Amino acids; Antivirals; Peptides
  • Mechanism of Action HIV fusion inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 09 Sep 2005 ViroLogic is now called Monogram Biosciences
  • 06 Jan 2004 Suspended - Phase-I/II for HIV infections in USA (SC)
  • 18 Sep 2003 Data presented at the 43rd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the adverse events and Viral Infections therapeutic trials section ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top